ResApp Health Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
12.90
-
-
269.80
-
Gross Income
12.90
-
-
269.80
-
SG&A Expense
457.40
662.10
3,287.50
11,105.70
7,480.00
EBIT
579.00
662.10
3,287.50
11,375.60
7,614.90
Unusual Expense
-
142.30
-
-
-
Non Operating Income/Expense
0.90
7.80
2.70
4.90
998.60
Interest Expense
-
-
-
-
4.10
Pretax Income
578.40
489.30
3,207.60
11,176.10
6,533.40
Income Tax
-
-
-
1,143.40
-
Consolidated Net Income
578.40
489.30
3,207.60
10,032.80
6,533.40
Net Income
578.40
489.30
3,207.60
10,032.80
6,533.40
Net Income After Extraordinaries
578.40
489.30
3,207.60
10,032.80
6,533.40
Net Income Available to Common
578.40
489.30
3,207.60
10,032.80
6,533.40
EPS (Basic)
0.00
0.00
0.01
0.02
0.01
Basic Shares Outstanding
172,122.70
205,330.10
491,713.80
655,481.00
659,039.60
EPS (Diluted)
0.00
0.00
0.01
0.02
0.01
Diluted Shares Outstanding
172,122.70
205,330.10
491,713.80
655,481.00
659,039.60
EBITDA
579.00
662.10
3,287.50
11,105.70
-
Other Operating Expense
108.60
-
-
-
134.90
Non-Operating Interest Income
1.50
22.80
82.60
204.30
87.00

About ResApp Health

View Profile
Address
127 Creek Street
Brisbane Queensland (QLD) 4000
Australia
Employees -
Website http://www.resapphealth.com.au
Updated 07/08/2019
ResApp Health Ltd. engages in the research and commercial development of drugs. It develops smart phone medical applications for the diagnosis and management of respiratory disease. The technology is based on a machine learning algorithm that uses sound alone without the need for additional hardware to diagnose and measure the severity of a respiratory condition.